Engerix-B Related Clinical Trials
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines [Completed]
Study of Evaluating Safety and Immunogenicity of 10�g/0.5ml Hepatitis B Vaccine [Completed]
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060) [Completed]
Hepatitis B Vaccine Booster Study (V232-058) [Completed]
A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) [Completed]
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine [Completed]
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults [Active, not recruiting]
Adolescents' Response to Hepatitis B Vaccine Booster Dose [Recruiting]
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines [Completed]
Combination Therapy of Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients [Recruiting]
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B [Completed]
Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People [Completed]
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis [Completed]
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B [Completed]
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand [Recruiting]
"Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection [Recruiting]
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 [Completed]
Hepatitis B Seroepidemiology Among Young Adults [Recruiting]
Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects [Recruiting]
Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients [Not yet recruiting]
Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant [Completed]
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection [Recruiting]
The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion [Recruiting]
Immune Response in Patients With Hepatitis B and C Infection [Recruiting]
Lamivudine and Adefovir to Treat Chronic Hepatitis B [Completed]
Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) [Active, not recruiting]
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy [Recruiting]
Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy [Active, not recruiting]
Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients [Recruiting]
Long-Term Lamivudine Therapy for Chronic Hepatitis B [Completed]
Community-Based Hepatitis B Interventions for Hmong Adults [Enrolling by invitation]
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis [Recruiting]
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule [Completed]
Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B [Recruiting]
Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background [Recruiting]
Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B [Recruiting]
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients [Active, not recruiting]
Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers [Completed]
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B [Active, not recruiting]
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Subjects With Chronic Hepatitis B and Who Are Currently Not on Treatment [Recruiting]
Observational Study of Persons With Hepatitis B Virus Infection in North America [Recruiting]
A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon [Recruiting]
Investigation of Hepatitis B and Hepatitis C in Taiwan [Completed]
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma [Completed]
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers [Completed]
Hepatitis B Vaccine Clinical Trial [Completed]
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Completed]
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Completed]
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B [Recruiting]
Entecavir for Chronic Hepatitis B [Completed]
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection [Recruiting]
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen [Completed]
Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination [Withdrawn]
Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients [Withdrawn]
Hepatitis B Vaccination in HIV-infected Persons [Completed]
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection [Completed]
Patient-Centered Care and Asian Americans [Active, not recruiting]
This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age [Completed]
Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals [Completed]
A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients [Recruiting]
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting [Completed]
The Influence of Short-term Starvation on Hepatitis B Virus Load [Not yet recruiting]
Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients [Not yet recruiting]
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Recruiting]
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B [Completed]
Study of ARC-520 in Patients With HBeAg (Hepatitis B e Antigen) Positive Chronic Hepatitis B Virus [Recruiting]
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B [Completed]
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir [Completed]
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection [Completed]
Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B [Not yet recruiting]
Efficacy and Safety of Telbivudine in Treatment na�ve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) [Terminated]
Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B [Completed]
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment [Completed]
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus [Completed]
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B [Completed]
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB). [Completed]
Health Promotion and Management for Hepatitis B Carriers [Active, not recruiting]
|
